Phlebologie, Table of Contents Phlebologie 2018; 47(05): 261-264DOI: 10.12687/phleb2437-5-2018 Kasuistik – Case report Georg Thieme Verlag KG Stuttgart · New York IgA antiphospholipid syndrome – a rare clinical variant Article in several languages: deutsch | English S. Lutze 1 Klinik- und Poliklinik für Haut-und Geschlechtskrankheiten, Universitätsmedizin Greifswald, Greifswald , M. Ahmed 1 Klinik- und Poliklinik für Haut-und Geschlechtskrankheiten, Universitätsmedizin Greifswald, Greifswald , W. Konschake 1 Klinik- und Poliklinik für Haut-und Geschlechtskrankheiten, Universitätsmedizin Greifswald, Greifswald , G. Daeschlein 1 Klinik- und Poliklinik für Haut-und Geschlechtskrankheiten, Universitätsmedizin Greifswald, Greifswald , M. Jünger 1 Klinik- und Poliklinik für Haut-und Geschlechtskrankheiten, Universitätsmedizin Greifswald, Greifswald › Author Affiliations Recommend Article Abstract Full Text PDF Download Keywords KeywordsAntiphospholipid syndrome - beta-2-glycoprotein IgA - vasculopathy - ulcus cruris References Literatur 1 Hughes JP, Stovin PGI.. Segmental pulmonary artery aneurysms with peripheral venous thrombosis.. Br J Dis Chest 1959; 53: 19-27 doi:10.1016/S0007–0971(59)80106–6 2 Cervera R.. Antiphospholipid sydrome.. In: Thrombosis Research 2017; 151: 43-S47 DOI: 10.2016/S0049–3848(17)30066-X. 3 Gómez-Puerta JA, Cervera R.. Diagnosis and classification of the antiphospholipid syndrome.. In: Journal of autoimmunity 2014; 48–49: 20-25 DOI:10.1016/j.jaut.2014.01.006. 4 Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E. et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.. Ann Rheum Dis 2009; 68: 1428-1432. 5 Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E. et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.. Ann Rheum Dis 2015; 74: 1011-1018. 6 Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.. Arthritis Rheum 1999; 42: 1309-1311. 7 Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).. J Thromb Haemost 2006; 4: 295-306. 8 14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends Doruk Erkan a, Cassyanne L. Aguiar a, Danieli Andrade b, Hannah Cohen c,d, Maria J. Cuadrado e, Adriana Danowski f, Roger A. Levy g, Thomas L. Ortel h, Anisur Rahman c,d, Jane E. Salmon a, Maria G. Tektonidou i, Rohan Willis j, Michael D. Lockshin a 9 Sunderkötter C, Pappelbaum K, Ehrchen J.. Hautarzt 2015; 66: 589. https://doi.org/10.1007/s00105–015–3661–6 10 Davin J-C.. Henoch-Schonlein purpura nephritis. Pathophysiology, treatment, and future strategy.. Clinical journal of the American Society of Nephrology, CJASN 2011; 6 (03) 679-689 DOI: 10.2215/CJN.06710810.
